ETFs
G
WGS
GeneDx Holdings Corp
69.05
+2.76+4.16%Opening13:01 10/20 EDT
OPEN/PREV CLOSE66.52/66.29
TODAY RANGE66.01-70.87
VOL147.96K
MARKET CAP2.06B
52 WEEK RANGE32.21-170.87
AVG VOL (3M)724.17K
% TURNOVER0.50%
TURNOVER--
P/E (TTM)-19.0289
% RANGE7.33%
EPS(TTM)-3.6287
P/E(FORWARD)-20.5812
P/B8.43
BVPS8.19
DIVIDEND--
P/S4.723
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.90B
SHARES OUTSTANDING29.82M
NEXT EARNINGS10/26-10/30
FREE FLOAT27.52M
LOT SIZE1
EX-DATE05/04/2023
News
Press Releases
Financial Reports
Profile
Simply Wall St·1d ago
GeneDx Stock Gets Attention After Newborn DNA Screening Results
Simply Wall St·6d ago
GeneDx Holdings (WGS) Could Be 28% Undervalued On Newborn Screening And Easy Order News
Simply Wall St·10/12 11:25
What Investors Overlooked Before GeneDx Slid
TipRanks·10/07 12:35
GeneDx presents new findings on genomic newborn screening at ICoNS 2026
Simply Wall St·10/06 23:29
GeneDx Holdings (WGS) Launches Easy Order As Pediatric Testing Narrative Shapes Valuation
Simply Wall St·10/03 10:18
How Easier Test Ordering Will Impact GeneDx Stock (WGS)
TipRanks·10/02 12:40
GeneDx to introduce Easy Order at AAP 2026
Dow Jones·10/01 13:56
GeneDx Holdings Is Maintained at Buy by Guggenheim
Dow Jones·10/01 13:56
GeneDx Holdings Price Target Raised to $83.00/Share From $74.00 by Guggenheim
Benzinga·10/01 13:46
Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $83
Same Industry
Name/Symbol
Change%
Price